6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0099 770-25-1-801-0137 -National CMOP FENOFIBRATE
ID: 36C77025Q0099Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/92735d62250141e0b88bcb8861a232f7/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate Pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP), under solicitation number 36C77025Q0099. The procurement requires multiple quantities of Fenofibrate 145MG 90CT, with specific delivery to various CMOP facilities across the United States, emphasizing compliance with the Buy American statute. This initiative is crucial for ensuring the availability of essential pharmaceuticals for veterans, reflecting the VA's commitment to providing timely medical supplies. Interested vendors must submit their proposals by December 30, 2024, at 09:00 AM CST, including a signed SF1449 cover page, a detailed price schedule in Excel format, proof of state wholesale distributor licensure, and a completed Buy American certificate, with all submissions directed to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.

    Point(s) of Contact
    McAlhaney, Michael W.Contract Specialist
    (913) 684-0134
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77025Q0099_1.docx
    The document outlines a Request for Proposal (RFP) for pharmaceutical supplies issued by the Department of Veterans Affairs' Network Contracting Office 15 (NCO 15). The RFP is aimed at securing specific drug products, particularly fenofibrate, with a focus on ensuring compliance with various regulations, including the Drug Supply Chain Security Act (DSCSA). Offerors must submit their proposals, including a signed solicitation cover page, a price schedule in Excel, and necessary certifications, by December 30, 2024. Key requirements include delivery to multiple locations within specified time frames and adherence to shipping protocols that allow products to be shipped via USPS. It emphasizes barcoding requirements for pharmaceutical products, including details for tracking shipments and handling recalls. The document mandates compliance with FDA standards for therapeutic equivalence and provides guidelines for invoicing and payment processes, which are to be conducted electronically. The solicitation also incorporates several Federal Acquisition Regulation (FAR) clauses essential for commercial contracts. Overall, this RFP illustrates the VA's commitment to obtaining safe and reliable pharmaceutical products while maintaining compliance with federal regulations and promoting the inclusion of various small business categories in federal contracting.
    36C77025Q0099.docx
    The Department of Veterans Affairs (VA) has issued a presolicitation notice for an emergency procurement of Fenofibrate Pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP). The solicitation number is 36C77025Q0099, with a response deadline of December 30, 2024, at 09:00 AM CST. The requirement includes multiple quantities of Fenofibrate 145MG 90CT, with specific delivery to various CMOP facilities across the U.S. All proposals must comply with the Buy American statute, and vendors are advised to provide quotes for both domestic and foreign products. The solicitation emphasizes the necessity for vendors to submit a signed SF1449 cover page, a detailed price schedule in Excel format, proof of state wholesale distributor licensure, and a completed Buy American certificate. The delivery timeframe is set for 10 days after receipt of the order, with shipping costs borne by the vendor. Interested parties must monitor the SWIFT platform for any amendments and submit their quotations via email to the specified contact. This procurement aims to enhance pharmaceutical availability for veterans, reflecting the federal government's commitment to providing essential medical supplies efficiently.
    52.225-2 BUY AMERICAN CERTIFICATE.docx
    The "Buy American Certificate" provision (FAR 52.225-2 OCT 2022) outlines the requirements for offerors in federal contracts regarding the origin of end products. The Offeror certifies that each end product, excluding some exceptions, is domestic and that those domestic products contain a critical component. If any end products are foreign, the Offeror must list them, along with their country of origin and their domestic content percentage—specifically indicating if it exceeds 55%. Furthermore, they must identify domestic end products containing a critical component. Key terms such as "commercially available off-the-shelf (COTS) item," "critical component," and "foreign end product" are defined in related documents. Evaluation of offers will conform to the policies of the Federal Acquisition Regulation's Part 25. This provision is essential for ensuring that federal procurement favors domestic products, thus supporting local economies and industries while complying with government procurement regulations.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0099.xlsx
    The document outlines a Request for Quotation (RFQ) from the VA, specifically RFQ 36C77025Q0099, for the procurement of Fenofibrate 145mg tablets in various quantities. The estimated issue date for this RFQ is December 20, 2024, with a close date of December 30, 2024, at 9:00 AM CST. Quotes should be emailed to designated VA personnel and must include required compliance documentation with the Drug Supply Chain Security Act (DSCSA), specifically state wholesale distributor licensure. The RFQ specifies detailed quantities and packaging requirements for the medication, each packaged in 90-count bottles. Respondents to the RFQ must ensure DSCSA compliance, providing necessary transaction records in specified formats by the delivery date of January 17, 2025. The document emphasizes the importance of strict adherence to compliance regulations and outlines systematic shipping addresses for various VA facilities. Overall, this procurement process reflects the government's commitment to ensuring secure and compliant sourcing of prescription medications for its facilities, aiming to enhance healthcare service delivery to veterans.
    Similar Opportunities
    6505--765_Pharmaceuticals_VA CMOP Hines_36C77025Q0088 765-25-1-021-0194 -Hines CMOP 4 PHARMACEUTICALS -(VA-25-00028394)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply various pharmaceuticals for delivery to the Consolidated Mail Outpatient Pharmacy (CMOP) in Hines, Illinois, under solicitation number 36C77025Q0088. The procurement includes specific items such as PEG-400 solution, Sevelamer carbonate tablets, Fenofibrate capsules, and Febuxostat tablets, with a total quantity specified for each item. These pharmaceuticals are essential for ensuring the health and well-being of veterans, highlighting the importance of a reliable supply chain in the healthcare sector. Interested vendors must submit their quotes, including a signed SF 1449 cover page and compliance documentation, by December 27, 2024, at 9:00 AM CST, with the estimated award date set for December 31, 2024. For further inquiries, vendors can contact Jeffrey A. Blackard at jeffrey.blackard@va.gov or by phone at (913) 684-0142.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0095 770-25-1-801-0132 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement for Ferrous Sulfate 324 mg EC Tablets, with a total quantity of 24,000 tablets to be delivered to multiple CMOP locations. The procurement requires compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that all products be bar-coded according to industry standards, ensuring safety and traceability. This solicitation underscores the VA's commitment to providing quality pharmaceutical supplies for its healthcare services, with a submission deadline for quotes set for December 30, 2024, at 9:00 AM CST. Interested vendors must submit their proposals, including a signed SF1449, an Excel price schedule, and a state wholesale distributor license, to the primary contact, Michael W McAlhaney, at Michael.McAlhaney@va.gov.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0059 762-25-1-040-0124 -Tucson CMOP ATORVASTATIN CALCIUM -(VA-25-00015524)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Atorvastatin Calcium 80mg tablets to be delivered to its Tucson CMOP facility. This contract is specifically set aside for small businesses and requires compliance with the Buy American statute, necessitating separate quotes for foreign and domestic products. The pharmaceuticals are critical for the healthcare of veterans, emphasizing the importance of responsible sourcing and regulatory compliance in the pharmaceutical supply chain. Interested vendors must submit their proposals via email to Jeffrey Blackard by December 26, 2024, at 09:00 AM Central Time, with the anticipated award date set for December 30, 2024.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0060 762-25-1-040-0111 -Tucson CMOP MIRTAZAPINE -(VA-25-00015396)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Mirtazapine 7.5mg tablets for delivery to the Tucson CMOP facility under solicitation number 36C77025Q0060. The procurement requires a total quantity of 5,280 tablets and emphasizes compliance with the Drug Supply Chain Security Act (DSCSA), as well as adherence to the Buy American statute, necessitating separate quotes for foreign and domestic products. This acquisition is crucial for ensuring a reliable supply of pharmaceuticals to support the health programs of veterans, with a response deadline set for December 27, 2024, and an estimated award date of December 31, 2024. Interested vendors must submit their quotes, including a signed SF1449 form, a completed price schedule in Excel format, and proof of state wholesale distributor licensure, to Jeffrey Blackard at jeffrey.blackard@va.gov.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    Chelmsford/Lancaster/Hines CMOPs MED/SURGE SUPPLIES ‐ 9‐line items
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking vendors to supply nine specific medical and surgical products for its Consolidated Mail Outpatient Pharmacy (CMOP) facilities located in Chelmsford, Lancaster, and Hines. The procurement involves a Request for Quote (RFQ) for essential medical supplies, including heat and moisture exchangers, latices, infusion sets, and reservoirs, with strict delivery timelines of ten days after receipt of order for most items. This initiative is crucial for maintaining adequate stock levels of medical supplies necessary for veteran care, ensuring compliance with the Buy American Act and other regulatory standards. Interested vendors must submit their proposals, including pricing and required certifications, by December 30, 2024, to Jennifer L. Knight at jennifer.knight@va.gov or via phone at 913-684-0162.